Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 12.59
+0.47 (3.88%)
Sep 30, 2026, 3:00 PM CST
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 24.9 billion as of October 2, 2026. Its market cap has decreased by -34.43% in one year.
Market Cap
24.90B
Enterprise Value
26.51B
Revenue
5.65B
Ranking
n/a
PE Ratio
33.11
Stock Price
12.59
ChartMarket Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 24.90B, an increase of 530.65%. That is a compound annual growth rate of 7.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 24.90B | -22.95% |
| Dec 31, 2025 | 32.31B | -20.29% |
| Dec 31, 2024 | 40.54B | -20.49% |
| Dec 29, 2023 | 50.98B | 30.38% |
| Dec 30, 2022 | 39.10B | -1.67% |
| Dec 31, 2021 | 39.77B | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Wantai Biological Pharmacy Enterprise | 33.48B |
| Chongqing Zhifei Biological Products | 31.31B |
| Suzhou Zelgen Biopharmaceuticals | 28.23B |
| Hualan Biological Engineering | 23.77B |
| Acrobiosystems | 20.56B |
| Xiamen Amoytop Biotech | 20.35B |
| Hebei Changshan Biochemical Pharmaceutical | 20.33B |
| Evopoint Biosciences | 18.99B |